109054 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against enzymes
Compositions for Modulating Cancer Stem Cells and Uses Therefor
#1202Exosomal loading using hydrophobically modified oligonucleotides
#1203Methods and compositions for inhibiting expression of LDHA
#1204METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
#1205PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY
#1206Compositions and methods for inhibiting expression of RRM2 genes
#1207METHOD OF OPTIMIZING COMPOUND SYNTHESIS REACTION BASED ON METABOLIC REACTION
#1208RNA targeting of mutations via suppressor tRNAs and deaminases
#1209COMPOSITIONS AND METHODS FOR REGULATION OF IMMUNE CELL ACTIVATION AND PROLIFERATION
#1210Treatments of oxidative stress conditions
#1211Compositions and methods for treatment of sepsis-related disorders
#1212PREDICTING AGE-RELATED MACULAR DEGENERATION WITH SINGLE NUCLEOTIDE POLYMORPHISMS WITHIN OR NEAR THE GENES FOR COMPLEMENT COMPONENT C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715
#1213siRNA compositions that specifically down regulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease
#1214RNAi-BASED THERAPEUTICS FOR TARGETING HTRA1 AND METHODS OF USE
#1215Methods and compositions for selecting siRNA of improved functionality
#1216GLUCOSYL TRANSFERASE POLYPEPTIDES AND METHODS OF USE
#1217METHOD FOR PREVENTING ORAL CANCER
#1218Combination therapy of lymphoma
#1219PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER, CONTAINING MALATE-ASPARTATE SHUTTLE INHIBITOR AND ANTICANCER DRUG AS ACTIVE INGREDIENTS
#1220Complement component iRNA compositions and methods of use thereof
#1221RNA targeting of mutations via suppressor tRNAs and deaminases
#1222COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA
#1223Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
#1224Method for treating a neurological disorder comprising administering ASM inhibitors
#1225Selenium Cancer Therapy
#1226Therapeutic compositions
#1227Methods of treating cancer using LSD1 inhibitors in combination with immunotherapy
#1228Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors
#1229POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF
#1230SOD1 dual expression vectors and uses thereof
#1231Antisense oligomers targeting PCSK9
#1232Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels
#1233METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER
#1234Extracellular matrix-producing composition using MAST4 gene and preparation method therefor
#1235Gene therapy treatment of atrial fibrillation
#1236USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#1237Method and composition for targeted delivery of therapeutic agents
#1238Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#1239SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#1240ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES, THE HCHWA-D MUTATION, AND TRINUCLEOTIDE REPEAT EXPANSIONS
#1241Immunosuppression-reverting oligonucleotides inhibiting the expression of CD39
#1242MODULATION OF IMMUNE RESPONSE THROUGH STIMULATOR OF INTERFERON GENES
#1243Therapeutic targeting of SET1B/compass pathway for treating cancers
#1244Methods of inhibiting cell proliferation and METTL8 activity
#1245Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#1246Methods and compositions for improving exercise endurance, performance, or tolerance
#1247PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
#1248Products and compositions
#1249METHODS FOR TREATING INFLAMMATION AND RELATED DISEASES AND DISORDERS BY INHIBITING ALPHA PROTEIN KINASE 1
#1250METHODS AND COMPOSITIONS FOR EFFICIENT DELIVERY THROUGH MULTIPLE BIO BARRIERS
#1251COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO
#1252Modulatory polynucleotides
#1253Nucleic acid-loaded unit polyion complex
#1254Modulators of PCSK9 expression
#1255Methods and compositions for the treatment of obesity
#1256PKLR inhibition in the treatment of NAFLD and HCC
#1257COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION
#1258GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION
#1259COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#1260USP30 INHIBITORS AND METHODS OF USE
#1261Methods of treating neurodegenerative disease by inhibiting N-deacetylase N-sulfotransferase
#1262Ketohexokinase (KHK) iRNA compositions and methods of use thereof
#1263METHODS OF INHIBITING FUNGAL CERAMIDE SYNTHASE FOR TREATMENT OF CRYPTOCOCCUS NEOFORMANS INFECTION
#1264GENES AND POLYMORPHISMS ASSOCIATED WITH AGE RELATED MACULAR DEGENERATION (AMD)
#1265Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
#1266Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
#1267Mammalian cells for producing a secreted protein
#1268Immunosuppression-Reverting Oligonucleotides Inhibiting the Expression of IDO
#1269Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#1270Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#1271COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#1272Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#1273ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION
#1274Oligonucleotide compositions and methods of use thereof
#1275METHODS AND COMPOSITIONS RELATING TO ANTI-CALCIFICATION
#1276Transbiotic Regulation of Bacterial Gene Expression
#1277MODULATORS OF COMPLEMENT FACTOR B
#1278Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
#1279Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA
#1280Methods and compositions for treating a proprotein convertase subtilisin kexin (PCSK9) gene-associated disorder
#1281Fidgetin-like 2 as a target to enhance wound healing
#1282Modulators of PNPLA3 expression
#1283COMPOSITIONS AND METHODS FOR TREATING CANCER
#1284Compositions and methods for the treatment of myotonic dystrophy
#1285Lipid compositions
#1286Enzymatic replacement therapy and antisense therapy for Pompe disease
#1287Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#1288Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
#1289m6A mRNA MODIFICATION IN CANCER TREATMENT
#1290SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT
#1291siRNA Targeting LDHA
#1292Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2
#1293Methods and pharmaceutical compositions for the treatment of diseases associated with reduced CFTR function
#1294PANCREATIC CANCER TARGETS AND USES THEREOF
#1295NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#1296Gemcitabine Derivatives for Cancer Therapy
#1297Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#1298TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A CHST15 INHIBITOR
#1299METHODS FOR TREATING AND PREVENTING ALLERGIES AND ACUTE ALLERGIC RESPONSES
#1300TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#1301Methods for Treating Obesity of a Subject Suffering from Obesity
#1302SELF-LIMITING CAS9 CIRCUITRY FOR ENHANCED SAFETY (SLICES) PLASMID AND LENTIVIRAL SYSTEM THEREOF
#1303Engineered immunostimulatory bacterial strains and uses thereof
#1304Methods of treating cancer harboring hemizygous loss of TP53
#1305Prevention and/or treatment of inflammatory skin disease
#1306CHIMERIC RNA OLIGONUCLEOTIDES AND USES THEREOF
#1307METHODS AND COMPOSITIONS FOR PROGNOSIS, DIAGNOSIS, AND TREATMENT OF ADAM8-EXPRESSING CANCER
#1308Amine-containing transfection reagents and methods for making and using same
#1309Oligonucleotides for inducing paternal UBE3A expression
#1310COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION
#1311Agents and methods for treating and preventing seborrheic keratosis
#1312METHOD AND KITS FOR IDENTIFYING OF CDK9 INHIBITORS FOR THE TREATMENT OF CANCER
#1313Protein kinase RNA-like endoplasmic reticulum kinase (PERK) inhibitors for prevention and/or treatment of lung injury and/or inflammation
#1314COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION
#1315Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
#1316Compositions for modulating SOD-1 expression
#1317Modulators of diacyglycerol acyltransferase 2 (DGAT2)
#1318COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA
#1319Methods of treating cancers containing fusion genes
#1320NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY KIT, AND NUCLEIC ACID DELIVERY METHOD
#1321NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF MASP2
#1322GENETICALLY MODIFIED CELL LINES FOR METABOLIC STUDIES
#1323Treatment of CNS injury with RNAi therapeutics
#1324Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#1325RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1326Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1327Lin28-mediated control of let-7 biogenesis
#1328Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression
#1329KINASE AND UBIQUITIN LIGASE INHIBITORS AND USES THEREOF
#1330METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
#1331METHODS OF TREATING ALZHEIMER'S DISEASE
#1332Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#1333Modulation of Factor 11 expression
#1334Compositions and methods for the production of pyruvic acid and related products using dynamic metabolic control
#1335P-coumaroyl-CoA:monolignol transferase
#1336REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#1337Methods and compositions of short small hairpin RNAs and microRNAs for wound healing
#1338Interfering RNA molecules
#1339NTRK2 FUSIONS
#1340Prognostic methods and systems of treatment for acute lymphoblastic leukemia
#1341Methods and compositions for the activation of gamma-delta T-cells
#1342Compositions and methods for the treatment and prevention of neurological disorders
#1343Methods for sub-typing and treating cancer
#1344Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
#1345Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene
#1346RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
#1347K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereof
#1348Compositions and methods for treating and preventing pancreatitis, renal injury and cancer
#1349Methods of Treating Angiogenesis-Related Disorders Using JNK3 Inhibitors
#1350Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia
#1351MUCOSAL HEALING PROMOTER
#1352siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof
#1353Car t-cells comprising inactivated CBL and CBL-B genes
#1354Methods and compositions for treating malignant tumors associated with KRAS mutation
#1355METHOD OF ELIMINATING STEM CELLS
#1356Compositions and methods for hemoglobin production
#1357Compositions and methods for regulating body weight and metabolic syndromes
#1358Compositions and methods for inhibiting gene expression of factor XII
#1359Lipids and lipid compositions for the delivery of active agents
#1360STEAP2 inhibitors for the treatment of liver cancers
#1361Methods and Compositions for Selecting siRNA of Improved Functionality
#1362METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING STEM CELLS PROLIFERATION OR DIFFERENTIATION
#1363TREATMENT OF SARCOMA
#1364Compositions and methods for reactivating latent immunodeficiency virus
#1365MODULATION OF TMPRSS6 EXPRESSION
#1366USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY
#1367Methods and materials for treating cancer
#1368SUGAR CHAIN-RELATED GENE AND USE THEREOF
#1369RNAI THERAPIES FOR CEREBRAL ISCHEMIA
#1370Consequences of a defective switch in cutaneous squamous cell carcinoma
#1371METHODS FOR ENHANCING VASCULAR DENSITY
#1372Methods of treating mitochondrial dysfunction
#1373SiRNA structures for high activity and reduced off target
#1374Therapeutic inhibition of lactate dehydrogenase and agents therefor
#1375Methods and Compositions for Selecting siRNA of Improved Functionality
#1376Oligonucleotide compositions with enhanced efficiency
#1377DELIVERY OF dsRNA TO ARTHROPODS
#1378RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1379Oligonucleotides for inducing paternal UBE3A expression
#1380Allele-specific silencing therapy for Dynamin 2-related diseases
#1381Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
#1382Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#1383Antisense oligonucleotides
#1384Compositions and methods for improving immune system function
#1385Inhibitors of cytoplasmic histone deacetylase 4 complex for treating or preventing vascular or valve calcification
#1386Methods and compositions for the treatment of cancer
#1387Recombinant protein-based method for the delivery of silencer RNA to target the brain
#1388Compositions and methods for reducing neointima formation
#1389Methods and compositions for in vivo induction of pancreatic beta cell formation
#1390Visceral adipose tissue macrophage-targeted gene/carrier complex for preventing or treating obesity-induced type II diabetes
#1391A NOVEL ROLE FOR TERMINAL RNA URIDYLATION AND RNA TURNOVER IN ONCOGENESIS
#1392Methods for treatment of cancer by targeting SIRT5
#1393IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
#1394Compositions and methods for mitochondrial genome editing
#1395Composition for gene therapy or transfection, and preparation method and use thereof
#1396Fidgetin-like 2 as a target to enhance wound healing
#1397TMPRSS6 iRNA compositions and methods of use thereof
#1398Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
#1399Viral vectors for treating Parkinson's disease
#1400Treatment of synucleinopathies
#1401Disruption of EGFR-SAR1 interaction for cancer treatment
#1402CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1403CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1404CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#1405Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
#1406RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1407CAMK2D antisense oligonucleotides and uses thereof
#1408Inhibition of KMT2D for the treatment of cancer
#1409THERAPEUTIC AGENT FOR PERIODONTITIS AND COMPOSTION FOR TREATING PERIODONTITIS
#1410Compounds and methods of promoting myelination
#1411Agents for improved delivery of nucleic acids to eukaryotic cells
#1412Inhibiting microRNA to prevent development of essential hypertension
#1413Modulation of gene expression and screening for deregulated protein expression
#1414Compound and method for treating myotonic dystrophy
#1415Therapeutic compositions
#1416METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS
#1417AAV delivery of shRNA for treatment of pancreatic cancer
#1418Cancer-treating pharmaceutical composition inhibiting expression of CCND3 or PAK2 gene
#1419Methods of modulating melanosome pH and melanin level in cells
#1420COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES
#1421Fibrotic treatment
#1422Antisense compounds and uses thereof
#1423Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1424Compounds and methods for reducing ATXN3 expression
#1425COMPOSITIONS AND METHODS FOR TREATING CANCER AND BIOMARKERS TO DETECT CANCER STEM CELL REPROGRAMMING AND PROGRESSION
#1426IDENTIFICATION AND USE OF TARGET GENES FOR CONTROL OF PLANT PARASITIC NEMATODES
#1427Antisense oligonucleotides useful in treatment of Pompe disease
#1428Modulators of DNM2 expression
#1429Lipid formulations for delivery of therapeutic agents
#1430Methods and compositions for selecting siRNA of improved functionality
#1431Methods of treating a wound using epigenetic regulation
#1432Modulation of prekallikrein (PKK) expression
#1433RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#1434COMPOSITIONS AND METHODS FOR TARGETING FRUCTOSE ENZYMES AND TRANSPORTERS FOR THE TREATMENT OF CANCER
#1435REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#1436Therapeutic compositions and methods of making and using the same
#1437INHIBITION OF PCSK9 THROUGH RNAI
#1438COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#1439DELIVERY OF NUCLEIC ACIDS, PROTEINS AND SMALL MOLECULES IN VITREOUS VESICULAR BODIES
#1440Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection
#1441Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#1442TMPRSS6 iRNA compositions and methods of use thereof
#1443Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#1444Modulators of telomere disease
#1445Neutral nanotransporters
#1446METHODS AND COMPOSITIONS FOR EXPANSION OF HEMATOPOIETIC STEM AND/OR PROGENITOR CELLS EMPLOYING A CYTOCHROME P450 1B1 (CYP1B1) INHIBITOR OR A MUSASHI-2 (MSI2) ACTIVATOR
#1447Modulation of PCSK9 and LDLR through DRP1 inhibition
#1448Methods and Pharmaceutical Compositions for Treating Lymphoid Malignancy
#1449METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR
#1450Increasing ATOH1 life to drive sensorineural hair cell differentiation
#1451Anabolic Enhancers for Ameliorating Neurodegeneration
#1452PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection
#1453CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1454CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1455Nucleus-encoded male sterility through mutation in cytochrome P450 oxidase
#1456Modulation of GYS1 expression
#1457Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#1458Use of Rad18 inhibitors in the treatment of tumors
#1459Natural cryptic exon removal by pairs of antisense oligonucleotides
#1460RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#1461Pharmaceutical composition containing mTOR inhibitor for treating macular degeneration
#1462INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING
#1463PIK3CA fusions
#1464EXOSOME SECRETION INHIBITOR
#1465Means and methods for modifying multiple alleles
#1466Compositions and Methods for Inhibiting Stem Cell Aging
#1467Production of itaconic acid
#1468Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
#1469Aminoalcohol lipidoids and uses thereof
#1470CRISPR-related methods and compositions with governing gRNAs
#1471Use of MIR101 or MIR128 in the treatment of seizure disorders
#1472Nucleic acids and methods for the treatment of Pompe disease
#1473Modified RNAi polynucleotides and uses thereof
#1474Conjugated lipomers and uses thereof
#1475Reduced size self-delivering RNAI compounds
#1476Means and methods to treat dystonia
#1477Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#1478Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#1479METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
#1480Method for significantly increasing lentiviral production
#1481Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)
#1482Compositions and methods for inhibiting expression of the ALAS1 gene
#1483Allele-specific gene suppression
#1484Products and methods for treatment of familial amyotrophic lateral sclerosis
#1485METHOD FOR MITIGATING METASTASIS
#1486Nucleic acid molecules encoding antibodies to the human glucagon receptor
#1487METHODS OF TREATING DISEASES ASSOCIATED WITH ILC3 CELLS
#1488Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition
#1489Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#1490Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases
#1491METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17
#1492Compositions and methods for inhibiting expression of TMPRSS6 gene
#1493Methods for improving cognitive function via modulation of quinone reductase 2
#1494Single-stranded oligonucleotide
#1495Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides
#1496Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
#1497Cancer therapy
#1498DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof
#1499Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
#1500Methods for identifying polymorphisms linked to the PPO11 gene